CASSELS: A firewall has to be built between pharmaceutical companies and physician training programs
CASSELS, LEVINSON, BOHM: With the availability of more medical tests also comes the risk of overtesting and overdiagnosis, worries Alan Cassels and doctors Wendy Levinson and Eric Bohm
PERRY, CASSELS: Funding was terminated for Cochrane Canada, part of the key global health care resource Cochrane Collaboration, in September
CASSELS: Why Canada’s ‘slow and low’ approach is the prudent one to take
CASSELS: Any national pharmacare program would need an absolute firewall to protect it from the inevitable politics of drug coverage
CASSELS and O’BRADY: Money would be better spent on increasing salaries and improving other benefits such as dental care
CASSELS: Drug treatment for female sexuality not about equality but profits
Breast cancer screening for rare genetic mutations doubles.